CD69 Is the Crucial Regulator of Intestinal Inflammation: A New Target Molecule for IBD Treatment? by Katarina Radulovic, Jan Hendrik Niess

Get full text

Risankizumab and Certolizumab Pegol Dual-Targeted Therapy for Crohn’s Disease and Axial Spondyloarthritis: A Case Report by Anouk Lehmann, Juerg Vosbeck, Diego Kyburz, Petr Hruz, Jan Hendrik Niess

Get full text

Fatigue Is Strongly Associated with Depressive Symptoms in Patients with Inflammatory Bowel Disease by Robin Mona, Andreas Göldi, Tobias Schneider, Isabelle Panne, Andrea Egger, Jan Hendrik Niess, Petr Hrúz

Get full text

XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease by Simon Woelfel, Joel Dütschler, Daniel Junker, Marius König, Georg Leinenkugel, Claudia Krieger, Samuel Truniger, Annett Franke, Seraina Koller, Katline Metzger-Peter, Nicola Frei, STAR SIGN Study Investigators, Werner C. Albrich, Matthias Friedrich, Jan Hendrik Niess, Nicole Schneiderhan-Marra, Alex Dulovic, Wolfgang Korte, Justus J. Bürgi, Stephan Brand

Get full text

Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel disease by Yasser Morsy, Åsa Walberg, Paulina Wawrzyniak, Barbara Hubeli, Luca Truscello, Celine Mamie, Ania Niechcial, Emilie Gueguen, Roberto Manzini, Claudia Gottier, Silvia Lang, Sylvie Scharl, Sena Blümel, Luc Biedermann, Gerhard Rogler, Matthias Turina, Michaela Ramser, Henrik Petrowsky, Isabelle C. Arnold, Sebastian Zeissig, Nicola Zamboni, Adrian Egli, Jan Hendrik Niess, Petr Hruz, Alexander Knuth, Ralph Fritsch, Markus G. Manz, Marcin Wawrzyniak, Michael Scharl

Get full text